SCHEMBL5346252

SCHEMBL5346252

[CH2]c1cccc(S(=O)(=O)O)c1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MYC P01106 1/20 0.44
TTR P02766 2/20 0.42
SNCA P37840 2/20 0.36
CYP1A2 P05177 3/20 0.36
CDK2 P24941 2/20 0.35
FABP4 P15090 1/20 0.35
CCNA2 P20248 1/20 0.35
MAPK14 Q16539 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
TSHR P16473 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NR4A1 P22736 1/20 0.34
COMT P21964 1/20 0.33
AURKA O14965 1/20 0.33
AURKB Q96GD4 1/20 0.33
ATIC P31939 1/20 0.33
SUMO2 P61956 1/20 0.33
SUMO1 P63165 1/20 0.33
SENP7 Q9BQF6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14101134 0.86 MYC (0.50) MYCTTRSNCACYP1A2CDK2
SCHEMBL4400073 0.80 MYC (0.46) MYCTTRSNCACYP1A2CDK2
SCHEMBL3780 0.80 MYC (0.46) MYCTTRSNCACYP1A2CDK2
SCHEMBL31506947 0.80 MYC (0.46) MYCTTRSNCACYP1A2CDK2
SCHEMBL9636011 0.80 TTR (0.44) MYCTTRSNCACYP1A2CDK2
SCHEMBL332245 0.79 TSHR (0.44) MYCTTRSNCACYP1A2CDK2
Formaldehyde SCHEMBL958923 0.79 TRPA1 (0.45) MYCTTRSNCACYP1A2CDK2
SCHEMBL2815041 0.78 MYC (0.44) MYCTTRSNCACYP1A2CDK2
SCHEMBL358507 0.78 MYC (0.44) MYCTTRSNCACYP1A2CDK2
Hydrochloric Acid SCHEMBL3138998 0.78 MYC (0.44) MYCTTRSNCACYP1A2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050026077-A1 Forming relief images; for ((opto)electronics; photoresists; mixture of binder and photoactivable compound SHIPLEY COMPANY, L.L.C. (US) 2005-02-03 US claimed
EP-1407324-A1 PHOTOIMAGEABLE COMPOSITION Shipley Company LLC (US) 2004-04-14 EP claimed
US-20030099899-A1 Photoimageable composition SHIPLEY COMPANY, L.L.C. 2003-05-29 US claimed
WO-2002091083-A1 PHOTOIMAGEABLE COMPOSITION SHIPLEY COMPANY, L.L.C. (US) 2002-11-14 WO claimed
US-7217490-B2 Processes for producing silane monomers and polymers and photoresist compositions comprising same SHIPLEY COMPANY, L.L.C. (US) 2007-05-15 US disclosed
US-7008750-B2 Processes for producing polysiloxanes and photoresist compositions comprising same SHIPLEY COMPANY, L.L.C. (US) 2006-03-07 US disclosed
US-20050026077-A1 Forming relief images; for ((opto)electronics; photoresists; mixture of binder and photoactivable compound SHIPLEY COMPANY, L.L.C. (US) 2005-02-03 US disclosed
US-6803171-B2 FOR FORMING RELIEF IMAGES; MANUFACTURING ELECTRONIC AND OPTOELECTRONIC DEVICE; USEFUL AS PHOTORESISTS SHIPLEY COMPANY L.L.C. 2004-10-12 US disclosed
EP-1455228-A1 Process for producing polysiloxanes and photoresist compositions comprising the same Shipley Co. L.L.C. (US) 2004-09-08 EP disclosed
EP-1407324-A1 PHOTOIMAGEABLE COMPOSITION Shipley Company LLC (US) 2004-04-14 EP disclosed
US-20030224286-A1 Processes for producing polysiloxanes and photoresist compositions comprising same SHIPLEY COMPANY, L.L.C. 2003-12-04 US disclosed
US-20030219676-A1 Processes for producing silane monomers and polymers and photoresist compositions comprising same SHIPLEY COMPANY, L.L.C. 2003-11-27 US disclosed
US-20030099899-A1 Photoimageable composition SHIPLEY COMPANY, L.L.C. 2003-05-29 US disclosed
WO-2002091083-A1 PHOTOIMAGEABLE COMPOSITION SHIPLEY COMPANY, L.L.C. (US) 2002-11-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030219676-A1 Processes for producing silane monomers and polymers and photoresist compositions comprising same PIN1, SAV1, PCNA MYC 1026/4885TTR 4558/4885SNCA 359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.